Ovatech Plans Pivotal Trial For Non-Hormonal Contraceptive Ring

Ovatech aims to begin a pivotal trial in April for its Ovaprene non-hormonal intravaginal silicone ring barrier contraceptive, pending FDA clearance of an investigational device exemption, the company said.

More from Archive

More from Medtech Insight